Physical Assessment. A physical assessment of each homogeneous area of suspect ACM was conducted to assess the friability and condition of the materials. A friable material is defined by the EPA as a material which can be crumbled, pulverized or reduced to powder by hand pressure when dry. Friability was assessed by physically touching suspect materials.
Physical Assessment. The physical assessment of the Dive Computer shall include a visual inspection for signs of damage or water leakage. The buttons, sounds, display, backlight, and water contact functionality on the Dive Computer also should be tested, consistent with the Service Manuals, to ensure they are functioning properly, including whether the Dive Computer’s temperature measurement and compass readings are accurate.
Physical Assessment. A complete physical assessment will be completed by either the physician, physician assistant or nurse practitioner as designated by the investigator. Physical Assessment will include height, weight, and review of body systems. See CRF’s for specific data points.
Physical Assessment. A. Clients must have a general physical examination at each initial and annual medical visit. The physical examination must include but not be limited to the following:
1. Height
2. Weight
3. Blood pressure
4. Thyroid
5. Heart
6. Lungs
7. Extremities
8. Breast
9. Abdomen
10. Pap smear as medically indicated
B. A client’s refusal or deferral of a service, including the reason for refusal and/or deferral must be documented in the client’s medical record.
C. Clients who decline or defer a service must be counseled regarding any possible health risks associated with declining and/or deferring the screening test or procedure. Counseling regarding any associated risk must be documented in the client’s medical record.
D. Physical examinations and laboratory testing should not be deferred beyond 3 months after the client’s visit unless in the clinician’s judgment there is a compelling reason to extend the deferral. All deferrals and the reason for the deferral must be documented in the client’s medical record.
E. Revisit schedules must be individualized, based upon the client’s need for education, counseling, and medical care. Younger clients and clients initiating a new contraceptive method may need to be scheduled for a revisit to reinforce proper use, check for side effects, and to provide additional information or clarification.
Physical Assessment. Appropriately obtain the patient’s consent to physical examination and maintain their privacy, dignity and comfort, complying with infection prevention and control procedures. Adapt the practice to meet the needs of different groups and individuals (including those with particular needs such as cognitive impairment or learning disabilities), working with chaperones where appropriate. Undertake observational and functional assessments of the patient relevant to their presenting condition to identify and characterise any abnormality. Apply a range of physical assessment techniques appropriately, systematically and effectively, informed by an understanding of the techniques’ respective validity, reliability, specificity and sensitivity and the implications of these limitations within an assessment. Identify, analyse and interpret potentially significant information from the physical assessment (including any ambiguities). Record the information gathered through assessments concisely and accurately, for clinical management and in compliance with local protocols, legal and professional requirements. Identify potential serious pathology and make the registered GP aware. Diagnose common problems that can usually be managed at first point of contact. Recognise how MSK conditions and their impact can interact with mental health, and identify when this is relevant. Understand how MSK problems may be a manifestation of injury not only from trauma but also abuse, recognising particular at-risk groups (such as older people with frailty and those with cognitive impairment) and take appropriate action when there are grounds for concern. Investigate appropriate investigative tests to aid diagnosis and assessment. Appraise the impact that a range of social, economic and environmental factors can have on outcomes for individuals with MSK conditions, their carers and their circles of support. Recognise and promote the importance of social networks and communities for individuals and their carers in managing an MSK condition. Promote the importance of physical activity for MSK health and advise on what people with MSK conditions can and should do. Promote the importance of diet and nutrition on MSK health (for example, adequate vitamin D for good bone health). Advise on the effects of injuries on MSK health and conditions. Advise on the effects of smoking, obesity and inactivity on MSK health and conditions and, where appropriate, promote change or refer to relevant services....
Physical Assessment. Client agrees to undergo a comprehensive physical assessment prior to commencement of any training sessions with MJP. In rare cases, MJP in its sole discretion may allow a Client to begin training prior to performance of the assessment, with the understanding that such Client will sign the required Waiver and Release of Liability and Indemnification prior to commencement of any training sessions, and that on-going training is subject to suspension for Client’s failure to timely provide the assessment, as detailed below. MJP will refer Client to an independent physical therapist located on site at MJP’s facility for an assessment, at no cost to Client, or Client may secure an assessment by a licensed physician or licensed physical therapist of Client’s choosing, at Client’s expense. Client agrees to authorize the person performing the assessment to disclose the results of the assessment to MJP, and to review same in detail with MJP, and MJP agrees to keep the results of Client’s assessment confidential and not disclose the contents of the assessment to any person outside of MJP and Nike, Inc.. CLIENT AGREES TO INDEMNIFY AND HOLD MJP HARMLESS FROM, AND TO LOOK SOLELY TO, THE PERSON(S) AND ENTITY THAT PERFORMED CLIENT’S ASSESSMENT FOR ANY LIABILITY, LOSS, COST OR EXPENSE THAT CLIENT MAY INCUR ATTRIBUTABLE TO ANY FAILURE OR OMISSION OF THE ASSESSMENT TO DETECT AN EXISTING MEDICAL CONDITION OF CLIENT THAT MIGHT BE ADVERSELY AFFECTED BY CLIENT’S PARTICIPATIONIN THE TRAINING SESSIONS WITH MJP. Client acknowledges and agrees that the failure of Client to provide a physical assessment of Client, performed by a licensed physician or licensed physical therapist, to MJP within one (1) week of Client’s first training session will result in the automatic suspension (without exception) of any future training sessions, until such time as Client provides the assessment to MJP. MJP is not obligated to make-up, or provide any refund for, any training sessions that are missed due to suspension for failure of Client to timely provide an assessment to MJP.
Physical Assessment. In an effort to promote physical fitness, the City will pay for a bi-annual physical 01887 (001) 69145 assessment of each employee to a wellness center of the City's choice.
Physical Assessment. Length: 1.5 hours • Discuss the value and limitations of various physical assessment procedures, including body temperature, pulse, blood pressure, respiratory rate, cervical lymph node inspection, throat examination, and physical inspection. • Demonstrate the procedures for conducting a systematic physical assessment and identify normal and critical findings. • Interpret physical assessment data and recognize limitations of the data. • Document patient assessment results. Length: 1.5 hours • Describe the basic process of specimen collection for point-of-care testing (POCT). • Identify a patient specimen that would be appropriate for a Clinical Laboratory Improvement Amendments (CLIA)-waived POCT. • Describe factors that can influence test performance. • Explain how test performance influences interpretation of test results. • Demonstrate the technique involved for the specimen collection types discussed. Length: 3.5 hours • Identify specific categories of patients who the pharmacist is authorized to test or screen for and treat minor, nonchronic health conditions. • Describe the physician’s instructions for obtaining relevant patient medical history for the purpose of identifying disqualifying health conditions, adverse reactions, and contraindications to the approved course of treatment. • Create a process and schedule for the physician to review the pharmacist’s actions under the protocol. • Identify a process and schedule for the pharmacist to notify the physician of the patient’s condition, tests administered, test results, and course of treatment. • Demonstrate ability to apply for CLIA waiver. • Develop a written protocol that includes all legally required components for legally authorized disease states and appropriate lab testing required. • Apply test and treat protocol information to patient-specific cases based on common pharmacy-based patient interactions.
Physical Assessment. Length: 1.5 hours • Discuss the value and limitations of various physical assessment procedures, including body temperature, pulse, blood pressure, respiratory rate, and visual inspection of skin. • Demonstrate the procedures for conducting a systematic physical assessment and identify normal and critical findings. • Interpret physical assessment data and recognize limitations of the data. • Document patient assessment results. Length: 1.5 hours • Describe the basic process of specimen collection for point-of-care testing (POCT). • Identify a patient specimen that would be appropriate for a Clinical Laboratory Improvement Amendments (CLIA)-waived POCT. • Describe factors that can influence test performance. • Explain how test performance influences interpretation of test results. • Demonstrate the technique involved for the specimen collection types discussed. Length: 3.5 hours • Identify specific categories of patients who the pharmacist is authorized to test or screen for and treat minor, nonchronic health conditions. • Describe the physician’s instructions for obtaining relevant patient medical history for the purpose of identifying disqualifying health conditions, adverse reactions, and contraindications to the approved course of treatment. • Create a process and schedule for the physician to review the pharmacist’s actions under the protocol. • Identify a process and schedule for the pharmacist to notify the physician of the patient’s condition, tests administered, test results, and course of treatment. • Demonstrate ability to apply for CLIA waiver. • Develop a written protocol that includes all legally required components for legally authorized disease states and appropriate lab testing required. • Apply test and treat protocol information to patient-specific cases based on common pharmacy-based patient interactions.
